(Q38941438)

7 September 2017

title

Synergistic Anti-Cancer Effects of Icariin and Temozolomide in Glioblastoma (English)

1 reference

7 September 2017

0 references

Lijuan Yang

1

1 reference

7 September 2017

Yuexun Wang

series ordinal

2

1 reference

7 September 2017

Hua Guo

series ordinal

3

1 reference

7 September 2017

Meiling Guo

series ordinal

4

1 reference

7 September 2017

publication date

11 November 2014

1 reference

Cell Biochemistry and Biophysics

7 September 2017

published in

1 reference

7 September 2017

volume

71

1 reference

7 September 2017

issue

3

1 reference

7 September 2017

page(s)

1379-1385

1 reference

Brain tumor survival: results from the National Cancer Data Base

7 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0360-3

Malignant astrocytic glioma: genetics, biology, and paths to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0360-3

Current management of glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0360-3

Current therapeutic paradigms in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0360-3

Enhanced proapoptotic effects of tumor necrosis factor-related apoptosis-inducing ligand on temozolomide-resistant glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0360-3

A first feasibility study of temozolomide for Japanese patients with recurrent anaplastic astrocytoma and glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0360-3

[Icariin and its pharmaceutical efficacy: research progress of molecular mechanism].

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0360-3

Icariin potentiates the antitumor activity of gemcitabine in gallbladder cancer by suppressing NF-κB

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0360-3

A novel anticancer agent, icaritin, induced cell growth inhibition, G1 arrest and mitochondrial transmembrane potential drop in human prostate carcinoma PC-3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0360-3

Icariin, a natural flavonol glycoside, induces apoptosis in human hepatoma SMMC-7721 cells via a ROS/JNK-dependent mitochondrial pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0360-3

Cytotoxic effects of Coptis chinensis and Epimedium sagittatum extracts and their major constituents (berberine, coptisine and icariin) on hepatoma and leukaemia cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0360-3

Icariin exterts negative effects on human gastric cancer cell invasion and migration by vasodilator-stimulated phosphoprotein via Rac1 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0360-3

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0360-3

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0360-3

Icariin isolated from Epimedium brevicornum Maxim attenuates learning and memory deficits induced by d-galactose in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0360-3

Resveratrol enhances the antitumor effects of temozolomide in glioblastoma via ROS-dependent AMPK-TSC-mTOR signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0360-3

Resveratrol abrogates the temozolomide-induced G2 arrest leading to mitotic catastrophe and reinforces the temozolomide-induced senescence in glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0360-3

Curcumin sensitizes human colorectal cancer xenografts in nude mice to gamma-radiation by targeting nuclear factor-kappaB-regulated gene products

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0360-3

NF-kappaB and cancer-identifying targets and mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0360-3

The NFκB pathway: a therapeutic target in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0360-3

NF-kappaB and STAT3 signaling in glioma: targets for future therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0360-3

NF-κB is activated in response to temozolomide in an AKT-dependent manner and confers protection against the growth suppressive effect of the drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0360-3

Propolis changes the anticancer activity of temozolomide in U87MG human glioblastoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0360-3

Triptolide synergistically enhances temozolomide-induced apoptosis and potentiates inhibition of NF-κB signaling in glioma initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0360-3

Inhibition of NF- κ B by Dehydroxymethylepoxyquinomicin Suppresses Invasion and Synergistically Potentiates Temozolomide and γ -Radiation Cytotoxicity in Glioblastoma Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0360-3

Celastrol synergistically enhances temozolomide cytotoxicity in melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0360-3

10.1007/S12013-014-0360-3

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

7 September 2017

1014273305

0 references

1 reference